Pediatric fiberbronchoscopy
Conditions
Interventions
Propofol/fentanyl group :intravenous injection of propofol 2.0 mg/kg, fentanyl 1µg/kg
propofol/esketamine group:intravenous injection of propofol 2.0 mg/kg, esketamine 0.75 mg/kg
Sponsors
People's Hospital of Ningxia Hui Autonomous Region
Eligibility
Sex/Gender
All
Age
2 Years to 12 Years
Inclusion criteria
Inclusion criteria: The children who were selected for fiberbronchoscopy under general anesthesia were 2-12 years old, ASA grade I to II, and weight was not limited.
Exclusion criteria
Exclusion criteria: Children with heart, liver and kidney function are obviously abnormal, coagulation function is abnormal, congenital heart disease, nervous system disease, mental disease, and allergic children to the study drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of transient hypoxemia (SpO2 < 90%); | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, pulse oxygen saturation;Total dosage of propofol, time of first addition of propofol, satisfaction of bronchoscopy physicians;Success rate of one-time bronchoscope placement;The incidence of complications; | — |
Countries
China
Contacts
Public ContactXiaomei Wang
People's Hospital of Ningxia Hui Autonomous Region
Outcome results
None listed